{
    "2019-10-11": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Pharma Stock Roundup: NVS' New Eye Drug Gets FDA Nod, NVO, GSK, PFE Sign Deals",
                "features": {
                    "keywords": [
                        "NVS",
                        "Eye Drug",
                        "FDA Nod",
                        "NVO",
                        "GSK",
                        "PFE",
                        "Deals"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Gilead-Galapagos Report Efficacy & Safety Results on RA Drug",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Galapagos",
                        "Efficacy",
                        "Safety",
                        "RA Drug"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}